Integumen was on life support when Gerry Brandon spotted the potential of its skin cloning technology. He acquired it, and a year later the stock is up 1,252 per cent. What’s next?
Irish companies are making their mark on the software-as-a-service industry – despite emerging concerns that the sector’s breakneck growth rate could hide the risk of a bubble.
© 2026 Currency Media Limited
